L-Lysine α-Oxidase: Enzyme with Anticancer Properties

Area of Science:

• Biochemistry
• Enzymology
• Cancer Research

Background:

• L-lysine α-oxidase (LO) is an L-amino acid oxidase with reported cytotoxic and antitumor activities.
• LO exhibits a dual mechanism of action involving L-lysine depletion and hydrogen peroxide (H₂O₂) generation.
• These mechanisms target tumor growth through distinct pathways.

Purpose of the Study:

• To review the molecular mechanisms underlying the biological action of L-lysine α-oxidase (LO).
• To evaluate the potential of LO as an anticancer enzyme, particularly for colon cancer treatment.
• To discuss recent findings on LO's efficacy in various tumor models.

Main Methods:

• In vitro and in vivo studies were conducted to assess LO's biological activities.
• Tumor models, including murine and human colon cancer xenografts (HCT 116, LS174T, T47D), were utilized.
• Data analysis focused on tumor growth inhibition and therapeutic effects (T/C values).

Main Results:

• LO demonstrated significant antitumor activity across multiple in vitro and in vivo studies.
• Prominent tumor growth inhibition was observed in human colon cancer xenografts, with maximum T/C values of 12% (HCT 116), 37% (LS174T), and 36% (T47D).
• The enzyme's dual mechanism, L-lysine depletion and H₂O₂ production, contributes to its anticancer effects.

Conclusions:

• L-lysine α-oxidase (LO) exhibits potent anticancer properties through a dual mechanism.
• Preclinical data strongly support the potential of LO as a therapeutic agent for colon cancer.
• Further investigation into LO's molecular mechanisms may reveal new anticancer strategies.